| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Sep―22 |
Guillain Barre Syndrome as a Complication of Infections Including COVID-19: a Review |
Shruti V. Kurup, Pratiksha M. Patil, Sonam S. Atkari, Sakshi R. Divate, Baban S. Thawkar, Mohan K. Kale |
| 2 |
[GO] |
2023―Feb―22 |
CD4 + Count: a Variable to Be Considered to Prioritize COVID-19 Vaccination in PLHIV |
Vakada Lakshmi Mounika, V. Udaya Kumar, Sameer Dhingra, V. Ravichandiran, Krishna Pandey, Vipan Kumar Parihar, Krishna Murti |
| 3 |
[GO] |
2022―Sep―09 |
Green Synthesis-Mediated Nanoparticles and Their Curative Character Against Post COVID-19 Skin Diseases |
Nivedhitha Kabeerdass, Selvankumar Thangaswamy, Vaithilingam Mohanasrinivasan, Chandrasekaran Rajasekaran, Selvakumar Sundaram, Thajuddin Nooruddin, Maghimaa Mathanmohun |
| 4 |
[GO] |
2022―Aug―06 |
Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an Insight |
Fathima A. S, Maxima Madhu, V Udaya Kumar, Sameer Dhingra, Nitesh Kumar, Sanjiv Singh, et al. (+2) V. Ravichandiran, Krishna Murti |
| 5 |
[GO] |
2022―Jun―28 |
Impact of COVID-19 on Antimicrobial Resistance in Paediatric Population: a Narrative Review |
Arya Karun, Rimple Jeet Kaur, Jaykaran Charan, Krishna Murti, M. Ramesh, V. Ravichandiran, Sameer Dhingra |
| 6 |
[GO] |
2022―Apr―01 |
Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models |
Mohamed Fadlalla, Mazin Ahmed, Musab Ali, Abdulrhman A. Elshiekh, Bashir A. Yousef |
| 7 |
[GO] |
2022―Mrz―08 |
Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach |
Rajan Rolta, Deeksha Salaria, Bhanu Sharma, Oladoja Awofisayo, Olatomide A. Fadare, Sonum Sharma, et al. (+5) Chirag N. Patel, Vikas Kumar, Anuradha Sourirajan, David J. Baumler, Kamal Dev |
| 8 |
[GO] |
2021―Aug―05 |
Evaluation of the Pharmacologic Treatment of COVID-19 Pandemic in Iraq |
Omeed Darweesh, Ghayth M. Abdulrazzaq, Radhwan N. Al-Zidan, Pshtiwan Bebane, Marwan Merkhan, Ruya Aldabbagh, Nohad AlOmari |
| 9 |
[GO] |
2021―Jul―15 |
Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach |
Rajan Rolta, Deeksha Salaria, PremPrakash Sharma, Bhanu Sharma, Vikas Kumar, Brijesh Rathi, et al. (+4) Mansi Verma, Anuradha Sourirajan, David J. Baumler, Kamal Dev |
| 10 |
[GO] |
2021―Apr―22 |
Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients? |
Myasar Alkotaji, Radhwan N. Al-Zidan |
| 11 |
[GO] |
2021―Mrz―02 |
Determination of Potential Drug Candidate Molecules of the Hypericum perforatum for COVID-19 Treatment |
Serap Yalçın, Seda Yalçınkaya, Fahriye Ercan |
| 12 |
[GO] |
2021―Feb―19 |
Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone |
Shivani Sood, Gurpreet Kaur Bhatia, Prachi Seth, Pawan Kumar, Jagjit Kaur, Vidisha Gupta, et al. (+2) Sandeep Punia, Hardeep Singh Tuli |
| 13 |
[GO] |
2021―Feb―03 |
Recent Advancement in SARS-CoV-2 Diagnosis, Treatment, and Vaccine Formulation: a New Paradigm of Nanotechnology in Strategic Combating of COVID-19 Pandemic |
Sushil Kumar Upadhyay, Siddhartha Dan, Mansi Girdhar, Kartikey Rastogi |
| 14 |
[GO] |
2020―Okt―22 |
Ayurveda and Allopathic Therapeutic Strategies in Coronavirus Pandemic Treatment 2020 |
Shivangi Talwar, Shivani Sood, Jayant Kumar, Ritu Chauhan, Mamta Sharma, Hardeep Singh Tuli |
| 15 |
[GO] |
2020―Sep―15 |
The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic |
Siddhartha Dan, Mohit Pant, Sushil Kumar Upadhyay |
| 16 |
[GO] |
2020―Aug―24 |
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2 |
Sairaj Satarker, Tejas Ahuja, Madhuparna Banerjee, Vignesh Balaji E, Shagun Dogra, Tushar Agarwal, Madhavan Nampoothiri |
| 17 |
[GO] |
2020―Jul―27 |
COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact |
Shivani Sood, Vaishali Aggarwal, Diwakar Aggarwal, Sushil K Upadhyay, Katrin Sak, Hardeep Singh Tuli, et al. (+3) Manoj Kumar, Jayant Kumar, Shivangi Talwar |
| 18 |
[GO] |
2020―Jul―18 |
Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update |
Puja Kumari, Kajal Rawat, Lekha Saha |
| 19 |
[GO] |
2020―Jul―18 |
Colchicine in COVID-19: an Old Drug, New Use |
Naomi Schlesinger, Bonnie L. Firestein, Luigi Brunetti |
| 20 |
[GO] |
2020―Jun―19 |
COVID-19 Drug Treatment in China |
Linzi Fan, Shuang Jiang, Xinrong Yang, Zhibin Wang, Chunjuan Yang |
| 21 |
[GO] |
2020―Mai―11 |
Hot Topic Commentary on COVID-19 |
Ah-Ng Kong, Andy T. Y. Lau, Luigi Brunetti |
| 22 |
[GO] |
2020―Mai―11 |
An Update on Current Therapeutic Drugs Treating COVID-19 |
Renyi Wu, Lujing Wang, Hsiao-Chen Dina Kuo, Ahmad Shannar, Rebecca Peter, Pochung Jordan Chou, et al. (+8) Shanyi Li, Rasika Hudlikar, Xia Liu, Zhigang Liu, George J. Poiani, Louis Amorosa, Luigi Brunetti, Ah-Ng Kong |
|
